E-mail: marketa.zaliova@lfmotol.cuni.cz
Odborné práce publikované na Linkos.cz
Přehled odborných textů publikovaných autorem na portálu Linkos.cz. Jsou zde uvedeny knihy a brožury, články v Klinické onkologii, tuzemská abstrakta z databáze abstrakt a další texty. Rejstřík není v žádném případě úplným autorským rejstříkem, protože jsou zde uvedeny pouze texty zveřejněné na portálu Linkos.cz.
Publikovaná abstrakta
- Acute Leukaemias with TEL/ABL Fusion: a Subgroup with Poor Prognosis and Prenatal Origin
- Backtracking Of The Genetic Events Preceding Acute Leukemia Diagnosis
- CONCURRENT DELETIONS OF IKZF1 AND PAX5, CDKN2A, CDKN2B OR PAR1 (IKZF1-PLUS) CONFER A VERY POOR PROGNOSIS IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA
- Defect in B Cell Production Driven By GATA2 Mutation Results in Their Absolute Reduction and Mature Phenotype in Pediatric Patients
- Dynamics and Evolution of the Preleukemic Clone in Slow Onset Leukemias
- Epigenetic Changes in CEBPα Gene and Xenotransplantation Model of B Cell Precursor Acute Lymphoblastic Leukemia Switching to Monocytoid Lineage During the Early Phase of the Treatment
- Epigenetic Status Of CEBPA Promoter and Expression Of CEBPα Correlates With Molecular Genetic Subtype and CD2 Aberrant Expression In B Cell Precursor ALL
- Epor Over-Expression In TEL-AML1 Positive ALL: Critical Roles for DNA Methylation, GATA-2 or MicroRNAs?
- ERG DELETION EXERTS A CD2-DEPENDENT POSITIVE PROGNOSTIC IMPACT ON IKZF1-DELETED CHILDHOOD ALL
- ETV6/RUNX1 DIRECTLY DYSREGULATES GENES WITH RUNX1 BINDING SITE VIA MECHANISM REVERSIBLE BY HISTONE DEACETYLASE INHIBITORS
- ETV6/RUNX1 Dysregulates Genes with RUNX1 Binding Site Via Mechanism Reversible by Histone Deacetylase Inhibitors
- Expression Profile of Selected HOX Genes in Different Childhood ALL Subtypes
- GENOMIC AND DRUG RESPONSE PROFILING OF FATAL TCF3-HLF-POSITIVE PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA IDENTIFIES RECURRENT MUTATION PATTERNS AND NOVEL THERAPEUTIC OPTIONS
- Characterization of Leukemias with ETV6-ABL1 Fusion
- IKZF1 DELETION STATUS DISCRIMINATES FOR OUTCOME IN IMATINIB-TREATED BCR-ABL1-POSITIVE CHILDHOOD ALL
- L-Asparaginase More Effectively Targets Leukemic Cells with Low Glycolytic Activity
- Modeling Resistance To Tyrosine Kinase Inhibitors In TEL/ABL-Positive Acute Lymphoblastic Leukemia
- MODELING RESISTANCE TO TYROSINE KINASE INHIBITORS IN TEL/ABL+ ACUTE LYMPHOBLASTIC LEUKEMIA
- Molecular Background of BCP-ALL Cases with an Early Switch to Monocytic Lineage
- MRD Monitoring Reveals a Specific Biology of BCR/ABL-Positive ALL
- MRD Monitoring Using Minor-BCR-ABL1 Genomic Breakpoint in Childhood ALL Identifies a Subgroup with Distinct Biology and a Very Poor Prognosis
- Multilevel Molecular Profiling to Dissect Resistance to Tyrosine Kinase Inhibitors in TEL/ABL Positive Acute Lymphoblastic Leukemia
- Potential Involvement of Physiological TCR Gamma Delta Clones in Immune Surveillance of Preleukemic Cells
- Prognostic Value of Rare IKZF1 deletions in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia: An International Collaborative Study
- Refinement of IKZF1 Genomic Status in Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
- RNAI MEDITED SILENCING REVEALS TEL/AML1 IS DISPENSABLE FOR LEUKEMIC CLONE SURVIVAL
- Silencing of TEL/AML1 In Definitive Leukemic Cells Does Not Impair Cell Survival
- The Central Region of TEL (ETV6) Is Dispensable for the TEL/AML1 (ETV6/RUNX1) Leukemogenesis
- THE PREVALENCE OF GATA-2 MUTATION AMONG PEDIATRIC PATIENTS WITH MYELODYSPLASTIC SYNDROME IN CZECH REPUBLIC
- The Role of Histone Demethylases in the Transcription Regulation of HOX Genes in PML-RARa+ AML Patients
- The Strong Prognostic Effect of Concurrent Deletions of IKZF1 and PAX5, CDKN2A, CDKN2B or PAR1 in the Absence of ERG Deletions (IKZF1plus) in Pediatric Acute Lymphoblastic Leukemia Strongly Depends on Minimal Residual Disease Burden after Induction Treatment
- TRACKING OF THE PRELEUKEMIC PERIOD IN SECONDARY ACUTE LEUKEMIAS REVEALS MULTIPOTENT PROGENITOR AS A TARGET OF MLL REARRANGEMENTS
- USE OF BCR/ABL GENOMIC BREAKPOINT FOR MRD MONITORING IN CHILDHOOD ALL AND ITS COMPARISON WITH OTHER STANDARD METHODS
